A detailed history of Contrarius Investment Management LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Contrarius Investment Management LTD holds 783,898 shares of CRSP stock, worth $32.1 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
783,898
Previous 685,716 14.32%
Holding current value
$32.1 Million
Previous $37 Million 0.56%
% of portfolio
2.1%
Previous 2.32%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$44.62 - $62.75 $4.38 Million - $6.16 Million
98,182 Added 14.32%
783,898 $36.8 Million
Q2 2024

Aug 13, 2024

BUY
$51.17 - $68.18 $1.01 Million - $1.34 Million
19,716 Added 2.96%
685,716 $37 Million
Q1 2024

May 10, 2024

BUY
$60.67 - $89.12 $29.3 Million - $43.1 Million
483,073 Added 264.08%
666,000 $45.4 Million
Q4 2023

Feb 12, 2024

SELL
$38.62 - $72.18 $1.46 Million - $2.73 Million
-37,808 Reduced 17.13%
182,927 $11.5 Million
Q3 2023

Nov 13, 2023

SELL
$45.39 - $59.0 $406,694 - $528,640
-8,960 Reduced 3.9%
220,735 $10 Million
Q2 2023

Aug 04, 2023

BUY
$43.47 - $67.77 $9.98 Million - $15.6 Million
229,695 New
229,695 $12.9 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.19B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Contrarius Investment Management LTD Portfolio

Follow Contrarius Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contrarius Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Contrarius Investment Management LTD with notifications on news.